{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:40:54Z","timestamp":1792590054698,"version":"4.5.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2019,4,23]]},"DOI":"10.1001\/jama.2019.3087","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T11:35:20Z","timestamp":1556019320000},"page":"1610","source":"Crossref","is-referenced-by-count":299,"title":["Reporting of Multi-Arm Parallel-Group Randomized Trials"],"prefix":"10.1001","volume":"321","author":[{"given":"Edmund","family":"Juszczak","sequence":"first","affiliation":[{"name":"NPEU Clinical Trials Unit, National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Altman","sequence":"additional","affiliation":[{"name":"Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Schulz","sequence":"additional","affiliation":[{"name":"FHI 360, Durham, North Carolina"},{"name":"the University of North Carolina at Chapel Hill, School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9940","key":"jsc190002r1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(14)61122-3","article-title":"More multiarm randomised trials of superiority are needed.","volume":"384","author":"Parmar","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"jsc190002r2","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1158\/1078-0432.CCR-08-0325","article-title":"Multi-arm clinical trials of new agents: some design considerations.","volume":"14","author":"Freidlin","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"2","key":"jsc190002r3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1001\/jama.1994.03520020048013","article-title":"Statistical power, sample size, and their reporting in randomized controlled trials.","volume":"272","author":"Moher","year":"1994","journal-title":"JAMA"},{"key":"jsc190002r4","doi-asserted-by":"publisher","first-page":"j917","DOI":"10.1136\/bmj.j917","article-title":"Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).","volume":"356","author":"Odutayo","year":"2017","journal-title":"BMJ"},{"key":"jsc190002r5","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"key":"jsc190002r6","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"jsc190002r7","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1371\/journal.pmed.0050020","article-title":"CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.","volume":"5","author":"Hopewell","year":"2008","journal-title":"PLoS Med"},{"issue":"10","key":"jsc190002r8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement.","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"8","key":"jsc190002r9","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2337\/dc14-0024","article-title":"HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin.","volume":"37","author":"Ahr\u00e9n","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"jsc190002r10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jamainternmed.2016.7491","article-title":"Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial.","volume":"177","author":"Agar","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"8","key":"jsc190002r11","doi-asserted-by":"publisher","first-page":"e021944","DOI":"10.1136\/bmjopen-2018-021944","article-title":"Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.","volume":"8","author":"Connick","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"jsc190002r12","first-page":"38","article-title":"Development of the Cochrane Collaboration\u2019s CENTRAL Register of controlled clinical trials.","volume":"25","author":"Dickersin","year":"2002","journal-title":"Eval Health Prof"},{"issue":"9712","key":"jsc190002r13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"issue":"9470","key":"jsc190002r15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/S0140-6736(05)66461-6","article-title":"Multiplicity in randomised trials I: endpoints and treatments.","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"jsc190002r16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/jama.2017.21242","article-title":"Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial.","volume":"319","author":"Foa","year":"2018","journal-title":"JAMA"},{"issue":"9949","key":"jsc190002r17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","article-title":"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u2019s disease (PD MED): a large, open-label, pragmatic randomised trial.","volume":"384","author":"Gray","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"jsc190002r18","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa066583","article-title":"Donepezil for the treatment of agitation in Alzheimer\u2019s disease.","volume":"357","author":"Howard","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"jsc190002r19","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"jsc190002r21","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.eururo.2013.09.051","article-title":"Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).","volume":"65","author":"Montorsi","year":"2014","journal-title":"Eur Urol"},{"issue":"9857","key":"jsc190002r22","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(12)61380-4","article-title":"Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial.","volume":"380","author":"Pickard","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"jsc190002r23","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming.","volume":"367","author":"Moss","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"jsc190002r24","doi-asserted-by":"publisher","first-page":"e50325","DOI":"10.1371\/journal.pone.0050325","article-title":"Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial.","volume":"7","author":"Ndibazza","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"jsc190002r25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.clinbiomech.2012.08.003","article-title":"Evaluation of combined prescription of rocker sole shoes and custom-made foot orthoses for the treatment of plantar fasciitis.","volume":"27","author":"Fong","year":"2012","journal-title":"Clin Biomech (Bristol, Avon)"},{"issue":"8","key":"jsc190002r26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism.","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"7139","key":"jsc190002r27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/bmj.316.7139.1236","article-title":"What\u2019s wrong with Bonferroni adjustments.","volume":"316","author":"Perneger","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"jsc190002r28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons.","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"issue":"4","key":"jsc190002r31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1081\/BIP-120024203","article-title":"Industry, government, and academic panel discussion on multiple comparisons in a \u201creal\u201d phase three clinical trial.","volume":"13","author":"Bauer","year":"2003","journal-title":"J Biopharm Stat"},{"issue":"5","key":"jsc190002r32","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1177\/0962280216664759","article-title":"Recommendations on multiple testing adjustment in multi-arm trials with a shared control group.","volume":"27","author":"Howard","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"jsc190002r33","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1745-6215-15-364","article-title":"Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?","volume":"15","author":"Wason","year":"2014","journal-title":"Trials"},{"issue":"20","key":"jsc190002r35","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1002\/(ISSN)1097-0258","article-title":"Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues.","volume":"22","author":"Sankoh","year":"2003","journal-title":"Stat Med"},{"issue":"6","key":"jsc190002r37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0197-2456(00)00106-9","article-title":"Practical guidelines for multiplicity adjustment in clinical trials.","volume":"21","author":"Proschan","year":"2000","journal-title":"Control Clin Trials"},{"key":"jsc190002r38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13063-015-0697-y","article-title":"Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice.","volume":"16","author":"Cohen","year":"2015","journal-title":"Trials"},{"issue":"4","key":"jsc190002r39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0141076818764320","article-title":"Avoiding bias in trials in which allocation ratio is varied.","volume":"111","author":"Altman","year":"2018","journal-title":"J R Soc Med"},{"issue":"13","key":"jsc190002r40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1056\/NEJMoa1400781","article-title":"A randomized trial comparing treatments for varicose veins.","volume":"371","author":"Brittenden","year":"2014","journal-title":"N Engl J Med"},{"key":"jsc190002r41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/3001478","article-title":"Multiple range and multiple F tests.","volume":"11","author":"Duncan","year":"1955","journal-title":"Biometrics"},{"key":"jsc190002r42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2307\/2983471","article-title":"V. T. Multiplicity considerations in the design and analysis of clinical trials.","volume":"159","author":"Cook","year":"1996","journal-title":"J Royal Stat Soc A Stat Soc"},{"key":"jsc190002r43","first-page":"MR000030","article-title":"Consolidated Standards of Reporting Trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.","volume":"11","author":"Turner","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"jsc190002r29","volume-title":"Clinical Trials: A Practical Approach","author":"Pocock","year":"1983"},{"key":"jsc190002r30","volume-title":"Statistical Issues in Drug Development","author":"Senn","year":"1997"},{"key":"jsc190002r36","volume-title":"Multiple Comparisons: Theory and Methods","author":"Hsu","year":"1996"},{"key":"jsc190002r14","unstructured":"European Medicines Agency. ICH Topic E 10: Choice of Control Group in Clinical Trials. Canary Wharf, London, United Kingdom: European Medicines Agency; 2001. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-10-choice-control-group-clinical-trials-step-5_en.pdf. Accessed February 14, 2018."},{"key":"jsc190002r20","unstructured":"DimarioM, ToddS, JuliousS, . Adaptive designs CONSORT Extension (ACE) Project Protocol: version 2.3. http:\/\/www.equator-network.org\/wp-content\/uploads\/2017\/12\/ACE-Project-Protocol-v2.3.pdf. Published 2016. Accessed February 14, 2018."},{"key":"jsc190002r34","unstructured":"European Medicines Agency. Guideline on Multiplicity Issues in Clinical Trials [draft]. Canary Wharf, London, United Kingdom: European Medicines Agency; 2017. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-multiplicity-issues-clinical-trials_en.pdf. Accessed February 14, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jama\/article-pdf\/321\/16\/1610\/17503470\/jama_juszczak_2019_sc_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T11:35:23Z","timestamp":1556019323000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2019.3087"}},"subtitle":["Extension of the CONSORT 2010 Statement"],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":43,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,4,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2019.3087","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,23]]}}}